The U.S. Food and Drug Administration (FDA) approved the liquid biopsy next-generation sequencing-based FoundationOne Liquid CDx test (Foundation Medicine, Inc.) as a companion diagnostic device for multiple additional biomarkers detected in ...
US regulators have approved Roche's new pan-tumour liquid biopsy test for patients with solid tumours, offering a potentially more convenient option and an alternative for patients unable to have tissue biopsy.